Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-23-021288

Options or other derivatives

  • Vice Pres Organizational Dev acquired 3,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Anthony Todd M. Vice Pres Organizational Dev 2023-03-24 Grant or award · Options (right to buy) +3,000 12,000 D
Loading xslF345X04/doc4.xml…